S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edmund S Kopetz, M.D.
M.D. Anderson
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
763 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Mercy Cancer Center-Hot Springs
Hot Springs, Arkansas, United States
- Fowler Family Center for Cancer Care
Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Veteran'S Administration Medical Center
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills - Peninsula Hospitals
Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Sutter Davis Hospital
Davis, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Kaiser Permanente Hospital
Fontana, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Kaiser Permanente
Fresno, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2014
- Primary completion
- 13 Nov 2017
- Completion
- 19 Nov 2020
- Last update posted
- 30 Dec 2020
- Registered enrollment
- 106
- Registry id
- NCT02164916
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.